Showing 3411-3420 of 19337 results for "".
Spotlight on Asia-Pacific: Practice Beyond Borders
https://reachmd.com/programs/cme/spotlight-on-asia-pacific-practice-beyond-borders/39810/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
https://reachmd.com/programs/cme/doublet-or-triplet-a-case-based-debate-in-first-line-choices-for-hrher2-mbc/39806/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Spotlight on Latin America: Closing the Gap
https://reachmd.com/programs/cme/spotlight-on-latin-america-closing-the-gap/39809/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
https://reachmd.com/programs/medical-industry-feature/latest-trop2-adc-approval-for-hr-her2-metastatic-breast-cancer/29175/There’s been recent progress with antibody-drug conjugates (ADCs) for HER2-negative breast cancers,1-3 and most recently, patients with metastatic HR+ HER2- breast cancer. The phase III TROPION-Breast01 study examined the efficacy and safety of datopotamab deruxtecan-dInk (Dato-DXd) compared to inveBehavioral Strategies for Managing Weight
https://reachmd.com/programs/lipid-luminations/behavioral-strategies-for-managing-weight/5386/This week's guest says that Americans eat an average of 200 calories more than they need every day. A variety of behavioral and emotional issues account for the reasons why. How can we help our patients change their habits? And what new habits will help them the most? The answer may lie in small chaSex, Skin, and the Endocrine Engine
https://reachmd.com/ma-issues-index/september-october-2025/sex-skin-and-the-endocrine-engine/39266/Why aesthetics needs a hormone upgradeUpdates to the McDonald Diagnostic Criteria for Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/updates-to-the-mcdonald-diagnostic-criteria-for-multiple-sclerosis/54595/The 2024 revisions to the McDonald diagnostic criteria enable earlier identification and treatment of multiple sclerosis and potentially improve long-term prognosis.The Psychosocial Dermal Axis
https://reachmd.com/topics/skincare/the-psychosocial-dermal-axis/35421/It’s time for psychiatry, dermatology, and aesthetic medicine to unite and explore.An Unusual Case of Adult-Onset Rapidly Progressive Leukoencephalopathy Associated With POLR3B-Related Sequence Variation
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/an-unusual-case-of-adult-onset-rapidly-progressive-leukoencephalopathy-associated-with-ipolr3bi-related-sequence-variation/35446/This presentation of a severe phenotype with late onset and rapid disease progression broadens the clinical spectrum associated with POLR3B pathogenic variants.Chimeric Antigen Receptor T-Cell Therapy for Progressive Multiple Sclerosis: Rationale, Evidence, and Therapeutic Potential
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/chimeric-antigen-receptor-t-cell-therapy-for-progressive-multiple-sclerosis-rationale-evidence-and-therapeutic-potential/56914/CAR T-cell therapy represents a new strategy for treating progressive multiple sclerosis by targeting pathogenic B cells involved in compartmentalized neuroinflammation.